Back to PE Pentwater Capital Management LP

HZNPHZNP
5 quarters

Position history for PEPentwater Capital Management LP's holdings in HORIZON THERAPEUTICS PUB L

As of its Q3 2023 13F, Pentwater Capital Management held 15,552,000 shares of HZNP (Horizon Therapeutics Pub), worth $1.8B. Pentwater Capital Management's 13F filings listed HZNP from Q4 2022 to Q3 2023, 4 quarterly filings. HZNP was 9.7% of Pentwater Capital Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$402.8M

Total Shares Change

-3.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q3
Increased
15.6M
+22.2%
$1.8B9.7%—
75
2023-Q2
Increased
12.7M
+108.6%
$1.3B9.0%—
100
2023-Q1
Increased
6.1M
+72.3%
$665.8M6.4%—
92
2022-Q4
New
3.5M
-
$402.8M7.1%—
96

Other major holders of HZNP: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used